IVRN (Innoveren Scientific) Change In Receivables: $0.02 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Change In Receivables?

Innoveren Scientific IVRN 16 Change In Receivables is $0.02 Mil as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

Innoveren Scientific's change in receivables for the quarter that ended in Sep. 2023 was $0.00 Mil. It means Innoveren Scientific's Accounts Receivable declined by $0.00 Mil from Jun. 2023 to Sep. 2023 .

Innoveren Scientific's change in receivables for the fiscal year that ended in Dec. 2022 was $0.01 Mil. It means Innoveren Scientific's Accounts Receivable declined by $0.01 Mil from Dec. 2021 to Dec. 2022 .

Innoveren Scientific's Accounts Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Innoveren Scientific's liquidation value for the three months ended in Sep. 2023 was $-11.14 Mil.

Innoveren Scientific  (OTCPK:IVRN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Innoveren Scientific's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0*91
=

2. In Ben Graham's calculation of liquidation value, Innoveren Scientific's accounts receivable are only considered to be worth 75% of book value:

Innoveren Scientific's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.544-11.679+0.75 * 0+0.5 * 0
=-11.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Change In Receivables Related Terms

Innoveren Scientific Change In Receivables Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Change In Receivables Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.04 0.01 -0.14 0.01

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 0.01 0.00 0.00 0.00
IVRN
16GF Score
Innoveren Scientific Inc IVRN
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.02 Mil mean?
Innoveren Scientific (IVRN) has a Change In Receivables of $0.02 Mil as of Sep. 2023. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Innoveren Scientific and its competitors.
Is Innoveren Scientific's Change In Receivables too high?
Innoveren Scientific's current Change In Receivables is $0.02 Mil. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Change In Receivables compare to GNCA and ISCO?
Innoveren Scientific's Change In Receivables of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Innoveren Scientific and its competitors. Innoveren Scientific's current Change In Receivables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Change In Receivables of $0.02 Mil. The current Change In Receivables is $0.02 Mil. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Change In Receivables is $0.02 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price